Loss of expression of transforming growth factor-β receptors is associated with poor prognosis in prostate cancer patients

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1625-1630

  Kim, Isaac Yi ^a,c   Ahn, Han Jong ^b   Lang, Sharon ^a   Oefelein, Michael G ^a   Oyasu, Ryoichi ^a   Kozlowski, James M ^a   Lee, Chung ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Asan Medical Center   (South Korea)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; SURVIVAL RATE;

HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SURVIVAL RATE;

EID: 0031776562     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
2. Wilding, G. Response of prostate cancer cells to peptide growth factors: transforming growth factor β. Cancer Surv., 11: 147-163, 1991.
3. Yang, E. Y., and Moses, H. L. Transforming growth factor β1-induced changes on cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol., 111: 731-741, 1990.
4. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., and Fauci, A. S. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA. 83: 4167-4171, 1986.
5. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., and Karlsson, S. Transforming growth factor ß1 mull mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA, 90: 770-774, 1993.
6. Wilding, G., Zugmeier, G., Knabbe, C., Flanders, K., and Gelmann, E. Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol. Cell. Endocrinol., 62: 79-87, 1989.
7. Goldstein, D., O'Leary, M., Mitchen, J., Borden, E. C., and Wilding, G. Effects of interferon β ser and transforming growth factor β on prostatic cell lines. J. Ural., 146: 1173-1177.
8. Thompson, T. C., Truong, L. D., Timme, T. L., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T., and Park, S. H. Transgenic models for the study of prostate cancer. Cancer (Phila.), 71: 1165-1171, 1993.
9. Truong, L. D., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T., and Thompson, T. C. Association of transforming growth factor β1 with prostate cancer: an immunohistochemical study. Hum. Pathol., 24: 4-9, 1993.
10. Eastham, J. A., Truong, L. D., Rogers, E., Kattan, M., Flanders, K. C., Scardino, P. T., and Thompson, T. C. Transforming growth factor β1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab. Invest., 73: 628-635, 1995.
11. Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M., and Geliebter, J. Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nat. Med., 1: 282-283, 1995.
12. Chang, H. L., Gillett, N., Figari, I., Lopez, A. R., Palladino, M. A., and Derynck, R. Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53: 4391-4398, 1993.
13. Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., and Derynck, R. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol., 118: 715-726, 1992.
14. Steiner, M., and Barrack, E. R. Transforming growth factor β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6: 15-25, 1992.
15. Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cell: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
16. Markowitz, S., Wang, J., Meyeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995,
17. Wang, J., Sun, L. Z., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., and Brattain, M. G. Demonstration that mutation of type II TGF-β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cell. J. Biol. Chem., 220: 22044-22049, 1995.
18. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
19. Lopez-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., and Massague, J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor. Cell, 67: 785-795, 1991.
20. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C., and Miyazono, K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75: 681-692, 1994.
21. Lin, H. Y., Wang, X., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992,
22. Chen, F., and Weinberg, R. A. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Nad. Acad. Sci. USA, 92: 1565-1569, 1995.
23. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
24. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J-H., Kato, M., and Lee, C. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
25. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Lange, S., Kato, M., Oefelein, M. G., Miyazono, K., Nemeth, J. A., Kozlowski, J. M., and Lee, C. Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res., 2: 1255-1261, 1996.
26. Gleason, P. F., Mellinger, G., and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58-64, 1974.
27. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.